Page last updated: 2024-08-22

didodecyldimethylammonium and Kahler Disease

didodecyldimethylammonium has been researched along with Kahler Disease in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jääskeläinen, I; Lappalainen, K; Ollikainen, H; Pulkki, K; Syrjänen, S1

Other Studies

1 other study(ies) available for didodecyldimethylammonium and Kahler Disease

ArticleYear
Liposomal targeting of bcl-2 antisense oligonucleotides with enhanced stability into human myeloma cell lines.
    Leukemia & lymphoma, 1996, Volume: 24, Issue:1-2

    Topics: Cations; Cell Differentiation; Cell Division; Drug Carriers; Drug Stability; Gene Expression Regulation, Neoplastic; Gene Targeting; Genes, bcl-2; Humans; Liposomes; Multiple Myeloma; Oligonucleotides, Antisense; Phosphatidylethanolamines; Quaternary Ammonium Compounds; Tumor Cells, Cultured

1996